Automated Blood Collection Market Overview
As per MRFR analysis, the Automated Blood Collection Market Size was estimated at 3.32 (USD Billion) in 2023. The Automated Blood Collection Market Industry is expected to grow from 3.65 (USD Billion) in 2024 to 7.17 (USD Billion) by 2032. The Market CAGR (growth rate) is expected to be around 7.78% during the forecast period (2024 - 2032).
Key Automated Blood Collection Market Trends Highlighted
Technological advancements, particularly in microfluidics and miniaturization, are driving innovation in the automated blood collection market. Integration with point-of-care (POC) testing systems enables real-time analysis and rapid diagnosis, enhancing patient care.
Key market drivers include the rising prevalence of chronic diseases, increasing demand for blood transfusions, and the need for accurate and efficient blood collection methods. Opportunities arise from expanding healthcare infrastructure in emerging markets and the integration of artificial intelligence (AI) for automated blood collection and analysis.
Recent trends include the adoption of finger-prick devices for non-invasive blood collection, the miniaturization of automated blood collection devices, and the emergence of wearable blood collection sensors for continuous monitoring. These innovations are expected to revolutionize blood collection and improve patient outcomes in the future.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Automated Blood Collection Market Drivers
Increasing Prevalence of Chronic Diseases
The rising prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular diseases, is a major driver of the Automated Blood Collection Market. These diseases require frequent blood tests for monitoring and diagnosis, which has led to an increased demand for automated blood collection systems.
Automated blood collection systems offer several advantages over traditional manual methods, including reduced risk of contamination, improved accuracy, and faster processing times. As a result, these systems are increasingly being adopted by hospitals, clinics, and other healthcare facilities.
Technological Advancements
The Automated Blood Collection Market is also being driven by technological advancements. New technologies, such as microfluidics and robotics, are being used to develop more sophisticated and user-friendly automated blood collection systems.
These systems can perform a wider range of tasks, such as sample preparation and analysis, which makes them more versatile and efficient. Additionally, the development of wireless and portable automated blood collection systems is making it easier to collect blood samples in remote or resource-limited settings.
Government Initiatives
Another factor contributing to the growth of the Automated Blood Collection Market is government actions aimed at improving healthcare infrastructure and access to healthcare services. Governments in various countries are providing funding and support for the development and deployment of automated blood collection systems, as they recognize their significance in enhancing the quality and efficiency of healthcare services.
Automated Blood Collection Market Segment Insights
Automated Blood Collection Market Type Insights
The Automated Blood Collection Market is segmented by type into automated blood collection devices, automated blood collection sets, automated blood collection tubes, and automated blood collection consumables.
In 2024, the automated blood collection devices segment is expected to dominate the market with a revenue of USD 1.81 billion, representing a market share of 40.2%. The growth of this segment can be attributed to the increasing adoption of these devices in hospitals, clinics, and blood banks due to their accuracy, efficiency, and reduced risk of contamination.
Automated blood collection sets are expected to witness a significant growth rate during the forecast period, owing to the growing demand for blood transfusions and the need for efficient blood collection procedures. These sets are designed to simplify the blood collection process, reduce the risk of errors, and improve patient safety.
Automated blood collection tubes are witnessing increasing adoption in clinical settings due to their ability to provide accurate and reliable blood samples. These tubes are pre-filled with anticoagulants and preservatives, which help in maintaining the integrity of the blood sample for longer periods.
Automated blood collection consumables, including needles, syringes, and other accessories, are essential components of automated blood collection systems. The growth of this segment is driven by the increasing demand for these consumables in hospitals, clinics, and research laboratories.
Overall, the type segment of the Automated Blood Collection Market is characterized by technological advancements, growing demand for efficient blood collection procedures, and increasing awareness about the benefits of automated systems.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Automated Blood Collection Market Application Insights
The Automated Blood Collection Market has been segmented based on application into diagnostic testing, therapeutic procedures, blood banking, and research and development. In 2023, diagnostic testing application accounted for the largest share of the market, and it is expected to hold its position during the forecast period. The high growth of the segment is attributed to the increasing prevalence of chronic disease which, in turn, drives the demand for accurate and timely diagnosis of the disease.
Therapeutic procedures is another major application of automated blood collection systems, and it is expected to grow at a significant rate in the upcoming years. The growing number of surgeries and the requirement for precise blood collection during surgical operations have positively influenced the adoption of automated blood collection systems in this segment.
Blood banking applications also account for an important application segment of these systems. Automated blood collection systems have enabled us to ensure the safety and efficiency of blood transfusions by reducing the risk of contamination and errors.
Another important application of this equipment is research and development. Research laboratories use automated blood collection systems for the collection of blood samples for various research purposes. The growing need for personalized medicine and the rising number of clinical trials are expected to drive the growth of this segment in the upcoming years.
Automated Blood Collection Market Technology Insights
The Automated Blood Collection Market segmentation by technology comprises vacuum-based devices, syringe-based devices, centrifugal devices, and microneedle devices. Among these, vacuum-based devices accounted for the largest revenue share in 2023, owing to their ease of use, reliability, and cost-effectiveness.
Syringe-based devices are expected to witness significant growth over the forecast period due to their accuracy and ability to collect larger blood volumes. Centrifugal devices offer advantages such as reduced hemolysis and improved sample quality, driving their demand in research and diagnostic applications. Microneedle devices are gaining traction due to their minimally invasive nature and potential for self-collection, making them suitable for point-of-care testing and home healthcare settings.
Automated Blood Collection Market End-User Insights
The end-user segment of the Automated Blood Collection Market is categorized into hospitals and clinics, diagnostic laboratories, blood banks, and research institutes. Hospitals and clinics hold the largest market share due to the high volume of blood tests performed in these settings.
Diagnostic laboratories also account for a significant share of the market, as they provide specialized blood testing services. Blood banks play a crucial role in collecting, storing, and distributing blood for transfusions, contributing to the market growth.
Research institutes are actively involved in developing and utilizing automated blood collection systems for clinical research and drug discovery. The increasing prevalence of chronic diseases, the growing demand for personalized medicine, and advancements in blood analysis technologies are driving the growth of the automated blood collection market across these end-user segments.
Automated Blood Collection Market Regional Insights
The Automated Blood Collection Market is segmented into North America, Europe, APAC, South America, and MEA. North America is expected to hold the largest share of the market in 2023, owing to the presence of many hospitals and clinics, as well as a high adoption rate of advanced healthcare technologies.
Europe is expected to be the second-largest market, followed by the APAC region. The APAC region is expected to witness significant growth over the forecast period, owing to the rising healthcare expenditure and increasing awareness of automated blood collection systems. South America and MEA regions are expected to account for a smaller share of the market due to lower healthcare spending and limited access to advanced healthcare technologies.
Source Primary Research, Secondary Research, MRFR Database and Analyst Review
Automated Blood Collection Market Key Players and Competitive Insights
Major players in the automated blood collection market are constantly striving to gain a competitive edge by introducing innovative products and expanding their global reach. Leading Automated Blood Collection Market players are investing heavily in research and development to enhance the efficiency and accuracy of their products.
The automated blood collection market development is driven by technological advancements and the increasing demand for automation in healthcare settings. The landscape of the automated blood collection market is highly competitive, with several key players vying for market share.
Roche is a leading company in the market. The company offers a wide range of automated blood collection systems, including the cobas p 312 and cobas p 512. Roche has a strong global presence and is known for its innovative products and high-quality standards. The company is constantly expanding its product portfolio and investing in research and development to maintain its leadership position.
BD is a major competitor in the automated blood collection market. The company offers a comprehensive range of blood collection products, including the BD Vacutainer and BD Vacutainer Plus. BD has a strong global presence and is known for its reliable products and customer service. The company is continuously developing new products and technologies to meet the evolving needs of its customers.
Key Companies in the Automated Blood Collection Market Include
- BD
- Danaher Corporation
- Tosoh
- QIAGEN
- Roche
- Thermo Fisher Scientific
- Agilent Technologies
- Ortho Clinical Diagnostics
- Beckman Coulter
- Sysmex
- Sysmex Corporation
- Abbott
- Siemens Healthineers
- BioRad Laboratories
Automated Blood Collection Market Developments
The Automated Blood Collection Market is poised to witness significant growth over the forecast period from 2023 to 2032. Rising prevalence of chronic diseases, increasing demand for blood transfusions, and technological advancements are key factors driving market expansion. The market is expected to reach a valuation of USD 5.1 billion by 2032, expanding at a CAGR of 5.01% from 2024 to 2032.
Recent developments in the market include the launch of new and innovative products, such as the BD Vacutainer RapidDraw™ Blood Collection System, which offers faster and more efficient blood collection. Strategic collaborations and acquisitions are also shaping the market landscape, with companies seeking to expand their product portfolios and geographical reach. Key players in the market include Becton, Dickinson and Company, Terumo Corporation, and Roche Diagnostics.
Automated Blood Collection Market Segmentation Insights
Automated Blood Collection Market Type Outlook
- Automated Blood Collection Devices
- Automated Blood Collection Sets
- Automated Blood Collection Tubes
- Automated Blood Collection Consumables
Automated Blood Collection Market Application Outlook
- Diagnostic Testing
- Therapeutic Procedures
- Blood Banking
- Research and Development
Automated Blood Collection Market Technology Outlook
- Vacuum-Based Devices
- Syringe-Based Devices
- Centrifugal Devices
- Microneedle Devices
Automated Blood Collection Market End-User Outlook
- Hospitals and Clinics
- Diagnostic Laboratories
- Blood Banks
- Research Institutes
Automated Blood Collection Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
3.32 (USD Billion) |
| Market Size 2023 |
3.65 (USD Billion) |
| Market Size 2032 |
7.17(USD Billion) |
| Compound Annual Growth Rate (CAGR) |
7.78% (2024-2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
BD, Danaher Corporation, Tosoh, QIAGEN, Roche, Thermo Fisher Scientific, Agilent Technologies, Ortho Clinical Diagnostics, Beckman Coulter, Sysmex, Sysmex Corporation, Abbott, Siemens Healthineers, BioRad Laboratories |
| Segments Covered |
Type, Application, Technology, End-User, Region |
| Key Market Opportunities |
1. Growth in emerging markets 2. Demand for precision and accuracy 3. Technological advancements 4. Point of care testing 5. Remote patient monitoring |
| Key Market Dynamics |
1. Rising healthcare costs 2. Growing geriatric population 3. Technological advancements |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The automated blood collection market is expected to reach USD 7.17 billion by 2032, exhibiting a CAGR of 7.78% during the forecast period (2024-2032).
North America is expected to dominate the market, accounting for a significant share in 2023 due to the presence of major market players, advanced healthcare infrastructure, and increasing adoption of automated blood collection systems.
Rising prevalence of chronic diseases, increasing demand for blood transfusions, technological advancements, and government initiatives to promote blood donation are driving the growth of the automated blood collection market.
Automated blood collection systems are primarily used in blood banks, hospitals, diagnostic laboratories, and research institutions for collecting blood samples for various tests and procedures.
Major players in the automated blood collection market include Terumo BCT, BD, Haemonetics, Fresenius Kabi, and Ortho Clinical Diagnostics.
The automated blood collection market is expected to reach USD 3.32billion in 2023.
